Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 313

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 313
---
 furnish to the Company and Merger Sub, copies of any notices or written communications received by such party or any of its Affiliates from any third party or any Governmental Authority with respect to the Transactions, and each party shall permit counsel to the other parties an opportunity to review in advance, and each party shall consider in good faith the views of such counsel in connection with, any proposed written communications by such party and/or its Affiliates to any Governmental Authority concerning the Transactions; provided that none of the parties shall extend any waiting period or comparable period or enter into any agreement with, or take or cause to be taken any action before, any Governmental Authority that is inconsistent with or intended to delay its action on requests for a consent or the consummation of the Transactions without the written consent of the Company and SPAC. To the extent not prohibited by Law, the Company agrees to provide SPAC and its respective counsel, and SPAC agrees to provide the Company and its respective counsel, the opportunity, on reasonable advance notice, to participate in any substantive meetings or discussions, either in person or by telephone, between such party and/or any of its Affiliates, their respective agents or advisors, on the one hand, and any Governmental Authority, on the other hand, concerning or in connection with the Transactions; •the Business Combination Agreement also contains additional covenants and agreements among the parties thereto in respect of, among other matters: (a)jointly preparing, filing and distributing this proxy statement/prospectus on Form F -4(including any amendments or supplements thereto); (b)duly calling and giving notice of, and convening and holding the SPAC Shareholders’ Meeting for the purpose of obtaining SPAC Shareholders’ Approval; (c)support of the business combination transaction from the Company, SPAC and Merger Sub; (d)tax matters, including with respect to the intended Tax treatment; (e)reasonably cooperating, providing and access to information; (f)indemnification of present and former directors and officers of the Company, SPAC and each of their Subsidiaries; (g)maintaining in effect liability insurances covering those persons who are currently covered by directors’ and officers’ liability insurance policies of the Company, SPAC and each of their Subsidiaries; (h)litigation matters with respect to the Business Combination; (i)using commercially reasonable efforts to obtain the PIPE Investment and consummating the transactions contemplated by the PIPE Subscription Ag